Upstream Biosciences Inc. today announced that it has entered into a collaboration with Makerere University in Kampala, Uganda with whom we plan to begin in vivo efficacy and toxicity testing of our novel compounds for the treatment of trypanosomiasis, or African sleeping sickness. According to the World Health Organization (WHO), an estimated 60 million people in sub-Saharan Africa are at risk ...
From: biz.yahoo.com
Upstream Biosciences to Collaborate With Makerere University for In Vivo Testing of Its Novel Agents to Treat African ...
Posted by Ruslan Abuzant at 5:38 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment